| |||||||||
Type Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Species laboratory mouse Generation N?+6 Donating Investigator IMR Colony, The Jackson Laboratory Description
Mice homozygous for the Mostm1Ev targeted mutation are viable. Homozygous males are fertile; the littersize of homozygous females is markedly lower than that of wild type or heterozygous mice. Eggs lacking Mos undergo spontaneous parthenogenetic activation (extrusion of the second polar body and pronucleus formation without fertilization). Ovarian cysts develop in homozygous females as young as one month. Some of the ovarian cysts consist of several tissue types, including possible thyroid tissue, similar to about 10% of all benign cystic teratomas in human beings.Development
The Mos-deficient strain was developed in the laboratory of Dr. Martin J. Evans at the University of Cambridge, UK. The targeting vector (containing the neo gene) was inserted into the middle of the single exon and introduced an amber stop codon, terminating translation of sequences essential for kinase activity. The construct was electroporated into 129S6/SvEv-derived CCE embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. Chimeric males were bred to generate heterozygotes. Heterozygotes were crossed to generate homozygotes.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| Considerations for Choosing Controls | ||
Strains carrying Mostm1Ev allele
002723 B6.129S6-Mostm1Ev/J 002404 B6;CBA-Mostm1Ev/J View Strains carrying Mostm1Ev (2 strains)
New 129 Nomenclature Bulletin
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Mostm1Ev/Mostm1Ev
involves: 129S/SvEv
- endocrine/exocrine gland phenotype
- ovary cysts (MGI Ref ID J:19118)
- ovarian cysts are found in 5 mutant females but not in wild-type (0/19) or heterozygous animals (0/10); incidence is high (4/7) in females older than 6 months
- cysts are serous, bilateral, multilocular in older mice and sometimes infiltrated with blood; smaller cysts are predominantly composed of epithelial tissue, while larger cysts (2/5) contain tissue types typical of a teratoma
- reproductive system phenotype
- *normal* reproductive system phenotype (MGI Ref ID J:77797)
- normal sperm count and spermatogenesis
- abnormal oogenesis (MGI Ref ID J:110272)
- in Mos-deficient oocytes the meiotic spindle does not migrate in contrast to wild-type; rather, it elongates dramatically followed by cortical polarization
- eggs isolated 18 hours after human chorionic gonadotropin treatment display 2 polar bodies and no pronuclei while egg from wild-type littermates have only one polar body
- ~40% of mutant eggs maintained in culture develop a pronucleus indicating parthenogenetic development; 30% of these cleave into 2 nucleated cells and occasionally to 4 cells
- mutant eggs that fail to cleave undergo cytoplasmic fragmentation which is not seen in wild-type eggs
- abnormal female meiosis (MGI Ref ID J:19118)
- eggs failed to arrest during meiosis, leading to spontaneous parthenogenetic activation (progress through meiosis II, germinal vesicle breakdown, extrusion of polar bodies, and cleavage)
- decreased litter size (MGI Ref ID J:19118)
- females have litters with average size of 2 pups, compared to wild-type and heterozygous females which have ~7 pups/litter
- ovary cysts (MGI Ref ID J:19118)
- ovarian cysts are found in 5 mutant females but not in wild-type (0/19) or heterozygous animals (0/10); incidence is high (4/7) in females older than 6 months
- cysts are serous, bilateral, multilocular in older mice and sometimes infiltrated with blood; smaller cysts are predominantly composed of epithelial tissue, while larger cysts (2/5) contain tissue types typical of a teratoma
- reduced female fertility (MGI Ref ID J:19118)
- females but not males have reduced fertility
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Mostm1Ev related
Cancer Research
Oncogenes
Reproductive Biology Research
Developmental Defects Affecting Gonads (parthenogenic activation)
Fertility Defects
Gonadal Tumors
| Allele Symbol | Mostm1Ev | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Martin L Evans | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | mos-/-; | ||
| Mutation Made By | M.J. Evans, University of Cambridge | ||
| Strain of Origin | 129S/SvEv-Gpi1c | ||
| ES Cell Line Name | CCE/EK.CCE | ||
| ES Cell Line Strain | 129S/SvEv-Gpi1 | ||
| Gene Symbol and Name | Mos, Moloney sarcoma oncogene | ||
| Chromosome | 4 | ||
| Gene Common Name(s) | MGC119962; MGC119963; MSV; c-mos; | ||
| Molecular Note | A neomycin resistance cassette was inserted into the middle of the single coding exon of the gene, introducing an amber stop codon into the reading frame and terminating translation upstream of sequences essential for kinase activity. [MGI Ref ID J:19118] | ||
Genotyping Protocols
Mostm1Ev, SEP PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Colledge WH; Carlton MB; Udy GB; Evans MJ. 1994. Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs [see comments] Nature 370(6484):65-8. [PubMed: 8015609] [MGI Ref ID J:19118]
Mostm1Ev relatedDumont J; Umbhauer M; Rassinier P; Hanauer A; Verlhac MH. 2005. p90Rsk is not involved in cytostatic factor arrest in mouse oocytes. J Cell Biol 169(2):227-31. [PubMed: 15837801] [MGI Ref ID J:98080]
Gross VS; Cooper GM. 2002. Functional analysis of sperm from c-mos-/- mice. Mol Reprod Dev 62(4):519-24. [PubMed: 12112586] [MGI Ref ID J:77797]
Hirao Y; Eppig JJ. 1997. Analysis of the mechanism(s) of metaphase I arrest in strain LT mouse oocytes: participation of MOS. Development 124(24):5107-13. [PubMed: 9362468] [MGI Ref ID J:45464]
Hirao Y; Eppig JJ. 1997. Parthenogenetic development of Mos-deficient mouse oocytes. Mol Reprod Dev 48(3):391-6. [PubMed: 9322252] [MGI Ref ID J:43317]
Naz RK; Rajesh C. 2005. Gene knockouts that cause female infertility: search for novel contraceptive targets Front Biosci 10:2447-2459. [PubMed: 15970507] [MGI Ref ID J:103183]
Oh B; Hampl A; Eppig JJ; Solter D; Knowles BB. 1998. SPIN, a substrate in the MAP kinase pathway in mouse oocytes. Mol Reprod Dev 50(2):240-9. [PubMed: 9590541] [MGI Ref ID J:47328]
Su YQ; Wigglesworth K; Pendola FL; O'Brien MJ; Eppig JJ. 2002. Mitogen-activated protein kinase activity in cumulus cells is essential for gonadotropin-induced oocyte meiotic resumption and cumulus expansion in the mouse. Endocrinology 143(6):2221-32. [PubMed: 12021186] [MGI Ref ID J:77527]
Verlhac MH; Kubiak JZ; Weber M; Geraud G; Colledge WH; Evans MJ; Maro B. 1996. Mos is required for MAP kinase activation and is involved in microtubule organization during meiotic maturation in the mouse. Development 122(3):815-22. [PubMed: 8631259] [MGI Ref ID J:32974]
Verlhac MH; Lefebvre C; Guillaud P; Rassinier P; Maro B. 2000. Asymmetric division in mouse oocytes: with or without Mos. Curr Biol 10(20):1303-6. [PubMed: 11069114] [MGI Ref ID J:110272]
Verlhac MH; Lefebvre C; Kubiak JZ; Umbhauer M; Rassinier P; Colledge W; Maro B. 2000. Mos activates MAP kinase in mouse oocytes through two opposite pathways EMBO J 19(22):6065-74. [PubMed: 11080153] [MGI Ref ID J:65991]
Colony Maintenance
Breeding & Husbandry Homozygous males are fertile while homozygous females have reduced fertility. When maintaining a live colony, this strain is maintained by mating heterozygous siblings. Alternatively, heterozygous females can be bred with homozygous males. Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.